Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.22.2.2
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Equity Compensation Plan by Arrangements

The following table contains information about the Company’s stock plan at September 30, 2022:

 

    Awards
Reserved for
Issuance
    Awards
Issued &
Exercised
    Awards
Available
for Grant
 
2013 Equity Compensation Plan     45,603 *     32,463 **     13,140  

 

* Increased by 8,651 thousand on January 1, 2022, representing 4% of the total number of shares of common stock outstanding on December 31, 2021.
** Includes both restricted stock grants and option grants
Schedule of Recognized Stock-Based Compensation

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2022     2021     2022     2021  
Research and Development   $ 554     $ 467     $ 1,660     $ 1,411  
General and Administrative     859       594       2,228       1,806  
Total   $ 1,413     $ 1,061     $ 3,888     $ 3,217  
Schedule of Stock Option Activity

The following table summarizes the activity for Company’ stock options for the nine months ended September 30, 2022:

 

    Stock Options  
Outstanding at December 31, 2021     28,184  
Granted     1,095  
Exercised     (195 )
Forfeited     (165 )
Cancelled     -  
Expired     (1,137 )
Outstanding at September 30, 2022     27,782